21% of healthcare employees worry about job security due to AI

In healthcare, 21 percent of employees are concerned about their job security due to the adoption of robotics and artificial intelligence (AI), according to a survey conducted by MindEdge.

AI in healthcare has grown exponentially over the past few years and now has niches in predicting infectious diseases, risk, patient outcomes, etc., but the growth of technology has also begun to worry healthcare workers who believe their jobs could be taken over by a machine. In the survey, which included responses of 1,000 Americans holding managerial positions or higher, researchers outlined implementation rates of robotics and AI, and the future of employees against automation.

Survey findings included:

  • 28 percent of the healthcare industry have adopted robotics of other forms of advanced automation.
  • 35 percent of managers in technology are concerned about their job security due to the adoption of robotics and automation.
  • 21 percent of employees working in the healthcare industry are concerned about their job security due to the adoption of robotics and automation.
  • 49 percent of managers working in technology say employees are lacking in soft skills, and stated 41 percent are lacking hard skills, in preparing for the adoption of robotics and automation.
  • 50 percent of managers believe it is a shared responsibility of both employees and employers in making sure employees are trained to work in the future of robotics and automation.
""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.